NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Medartis Holding AG (SW: MED)
MED Technical Analysis
5
As on 21st Nov 2024 MED STOCK Price closed @ 49.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 78.03 & Strong Sell for SHORT-TERM with Stoploss of 78.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MEDSTOCK Price
Open | 49.00 | Change | Price | % |
High | 51.00 | 1 Day | 0.65 | 1.33 |
Low | 48.40 | 1 Week | -4.90 | -9.01 |
Close | 49.50 | 1 Month | -5.10 | -9.34 |
Volume | 2518 | 1 Year | -21.60 | -30.38 |
52 Week High 94.70 | 52 Week Low 45.05 |
SW Switzerland Most Active Stocks
CSGN | 0.82 | 0.00% |
CSGN | 0.82 | 0.00% |
NESN | 75.96 | -0.73% |
NESN | 75.96 | -0.73% |
UBSG | 28.14 | -0.04% |
UBSG | 28.14 | -0.04% |
NOVN | 91.56 | 0.63% |
NOVN | 91.56 | 0.63% |
PRFN | 0.03 | 50.00% |
ARYN | 1.46 | -0.68% |
SW Switzerland Top Gainers Stocks
SW Switzerland Top Losers Stocks
MED Daily Charts |
MED Intraday Charts |
Whats New @ Bazaartrend |
MED Free Analysis |
|
MED Important Levels Intraday
RESISTANCE | 54.51 |
RESISTANCE | 52.90 |
RESISTANCE | 51.91 |
RESISTANCE | 50.92 |
SUPPORT | 48.08 |
SUPPORT | 47.09 |
SUPPORT | 46.10 |
SUPPORT | 44.49 |
MED Forecast November 2024
4th UP Forecast | 93.24 |
3rd UP Forecast | 79.21 |
2nd UP Forecast | 70.54 |
1st UP Forecast | 61.87 |
1st DOWN Forecast | 37.13 |
2nd DOWN Forecast | 28.46 |
3rd DOWN Forecast | 19.79 |
4th DOWN Forecast | 5.76 |
MED Weekly Forecast
4th UP Forecast | 62.03 |
3rd UP Forecast | 58.01 |
2nd UP Forecast | 55.53 |
1st UP Forecast | 53.04 |
1st DOWN Forecast | 45.96 |
2nd DOWN Forecast | 43.47 |
3rd DOWN Forecast | 40.99 |
4th DOWN Forecast | 36.97 |
MED Forecast2024
4th UP Forecast | 155.97 |
3rd UP Forecast | 121.82 |
2nd UP Forecast | 100.72 |
1st UP Forecast | 79.61 |
1st DOWN Forecast | 19.39 |
2nd DOWN Forecast | -1.72 |
3rd DOWN Forecast | -22.82 |
4th DOWN Forecast | -56.97 |
Medartis Holding AG ( SW Switzerland Symbol : MED )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MED Other Details
Segment | EQ | |
Market Capital | 1401593856.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
MED Address
MED Latest News
MED Business Profile
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for surgical fixation of bone fractures for upper and lower extremities, as well as for the craniomaxillofacial region. The company offers osteosynthesis systems for the areas of the hand, wrist, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, and cranium under the APTUS and MODUS names. The company serves the surgeons, hospitals, and medical centers, as well as group purchasing organizations. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland. Address: Hochbergerstrasse 60E, Basel, Switzerland, 4057
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service